The parent company of LloydsPharmacy has confirmed that it is making “some changes” to “have a sustainable business,” triggering speculations that a number of jobs across the multiple’s 1,500 pharmacies in the UK could be made redundant.
A spokesperson of McKesson UK told Pharmacy Business on Tuesday (July 7) that the impacts of Covid-19 was making the business, which was already operating in volatile marketplace, “even more uncertain”.
“The increased costs we face, alongside a reduction in income, mean that we need to respond in order to remain competitive,” the spokesperson of the multiple said, adding: “We are making some changes so that we have a sustainable business that helps our front-line colleagues in delivering integrated healthcare services to our customers and patients.
“Our business has evolved through the years by acquiring other companies which has led to some contractural differences amongst our colleagues.
“We want to make things fairer and more equitable across our company so we’ll be standardising our employee terms and conditions through a collective consultation.
“Our commitment is to support everyone impacted by these changes through regular two-way communication.”
More to follow…